Impact of experience with a retrograde-viewing device on adenoma detection rates and withdrawal times during colonoscopy: the Third Eye Retroscope study groupDisclosure
To access this article, please choose from the options below
Disclosure The following author disclosed a financial relationship relevant to this publication: D.C. DeMarco: Consultant for Spirus Medical. All other authors disclosed no financial relationships relevant to this publication.
Current affiliations: Baylor University Medical Center (D.C.D, E.O., L.F.L., J.K.H., D.P.), Dallas, Texas, North Hills Hospital (D.B.), North Richland Hills, Texas, S.W. Fort Worth Endoscopy Center (C.H. T.D., T.M.D.), Fort Worth, Texas, Hennepin County Medical Center (T.K., K.G.), Minneapolis, Minnesota, University of Texas Southwestern (L.W.), Dallas, Texas, NorthShore University HealthSystem (M.K.M.), Evanston, Illinois, Florida Hospital (M.B.A.), Celebration, Florida, University of Massachusetts (R.P.), Worcester, Massachusetts, University of Chicago (K.G.R., I.H.), Chicago, Illinois.
If you would like to chat with an author of this article, you may contact Dr. DeMarco at DanielD@BaylorHealth.edu.
PII: S0016-5107(09)02887-9
doi:10.1016/j.gie.2009.12.021
© 2010 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.
